FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

21 Sep 16

Cancer Genetics, Inc. to Present at Two Upcoming Investor Conferences During September (read more...)

- RUTHERFORD, N.J., Sept. 21, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in enabling (read more...)
20 Sep 16

Cancer Genetics, Inc. Announces a Global Partnership with BARC Global Central Laboratory to Offer Comprehensive Clinical Trial and Companion Diagnostic Solutions for the Oncology Industry (read more...)

- The companies have entered into an agreement to offer biotech and pharmaceutical companies access to BARC’s network of global central (read more...)

Events

Clinicians
Patients